Shelter Pharma Limited has submitted a regulatory filing to BSE Limited regarding the cancellation of its previously scheduled H2 FY2026 Investor Conference Call.
The filing serves as a corrigendum to the company's earlier intimation submitted to the Exchange on 05th June, 2026. That initial communication had announced an Investor Conference Call scheduled for Wednesday, 10th June, 2026. The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company now informs that due to unavoidable circumstances, the Investor Conference Call scheduled for 10th June, 2026 has been cancelled and will not be held as planned.
Shelter Pharma has stated that it will intimate the revised date and other details for the Investor Conference Call separately in due course. The company expressed regret for any inconvenience caused by this cancellation.